Amphastar Pharmaceuticals Q2 EPS $0.39 Beats $0.36 Estimate, Sales $123.47M Beat $119.30M Estimate
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.36 by 8.33 percent. This is a 85.71 percent increase over earnings of $0.21 per share
